Show results for
Refine by
Locations
- Europe
- Albania
- Andorra
- Austria
- Belarus
- Belgium
- Bosnia & Herzegovina
- Bulgaria
- Croatia
- Cyprus
- Czech Republic
- Denmark
- Estonia
- Faroe Islands
- Finland
- France
- Germany
- Greece
- Hungary
- Iceland
- Ireland
- Italy
- Kosovo
- Latvia
- Liechtenstein
- Lithuania
- Luxembourg
- Macedonia
- Malta
- Moldova
- Monaco
- Montenegro
- Netherlands
- Northern Ireland
- Norway
- Poland
- Portugal
- Romania
- San Marino
- Serbia
- Slovakia
- Slovenia
- Spain
- Sweden
- Switzerland
- Turkey
- Ukraine
- United Kingdom
- Vatican City
Precision Medicines Equipment Supplied In Europe
34 equipment items found
Manufactured by:Cytocast based inBudapest, HUNGARY
The CYTOCAST DIGITAL TWIN Platform represents a cutting-edge advancement in precision medicine, aiming to transform patient care through personalized treatment strategies. By integrating multi-omics data—such as genomic, proteomic, and metabolomic profiles—with detailed clinical information, this platform creates a precise digital ...
Manufactured by:Yourgene Health based inManchester, UNITED KINGDOM
Elucigene DPYD assay is a simple genotyping test that can identify patients with DPD deficiency allowing an alternative treatment to be offered. 5-fluorouracil (5-FU) is a chemotherapy agent used to treat a range of cancers including colorectal, head and neck, breast, pancreatic and stomach cancer. 5-FU is metabolized by the dihydropyrimidine dehydrogenase enzyme (DPD) which is encoded by the ...
Manufactured by:Ariana Pharma based inParis, FRANCE
Ariana Pharma has developed KEM® (Knowledge Extraction and Management) the most advanced Explainable Artificial Intelligence platform based on Galois Lattices (also known as Formal Concept Analysis or FCA). KEM® uses association rules to fully explore complex datasets in order to reveal hidden relationships and to derive new hypotheses. Ariana’s eXplainable Al reduces billions of ...
Manufactured by:Benevolent based inLondon, UNITED KINGDOM
The Benevolent Platform™ is our powerful computational R&D platform. At its core sits our Knowledge Graph, which captures the interconnectivity of all relevant available data and scientific literature. Our suite of exploratory and predictive AI tools allow scientists to interrogate the data and disease networks within the graph, ask biological questions, surface novel ...
by:STALICLA based inGeneve, SWITZERLAND
DDS applies AI-driven and systems biology precision medicine approaches to patient data sets. Bringing together computational biologists, human geneticists, data scientists, chemo-informaticians and developers, DDS ensures that STALICLA’s first-in-class DEPI technology is producing next-generation therapeutics for ...
by:STALICLA based inGeneve, SWITZERLAND
STALICLA’s precision medicine approach begins with ‘endophenotyping’-identifying the nonbehavioral physical and molecular presentations of NDDs and characterizing subgroups of patients with similar disease signatures. DEPI matches these patient subgroups with an NDD-targeted drug (or drug combination) by integrating and analyzing large omics ...
by:Oncodesign based inDijon, FRANCE
Oncodesign’s Pharmimage® technology module is a pharmaco-imaging module designed to monitor the effect of treatments and to define effective translational biomarkers in precision medicine. It includes translational, optical (bioluminescence, fluorescence), functional and molecular (MRI, PET, SPECT, CT scanner, MRI/PET coupling) multi-modal imaging ...
Manufactured by:Owlstone Medical Ltd. based inCambridge, UNITED KINGDOM
Non-invasive analysis of biomarkers on breath in early detection and precision medicine. Exhaled breath is more than just air, it contains over 1,000 volatile organic compounds (VOCs) as well as microscopic aerosol particles, also known as respiratory droplets, originating from the lungs and airways. Both VOCs and breath aerosol represent rich sources of ...
Manufactured by:Ardigen based inKraków, POLAND
We make bioinformatic workflows and software with human-readable code, as well as machine learning models that “understand” biological data and provide cutting-edge solutions for Precision ...
Manufactured by:betaSENSE based in, GERMANY
The platform supports the pharmaceutical research in drug discovery and clinical studies, offering reliable risk stratification of participants. Being rigorously tested, this platform represents a significant step in precision medicine, aimed at altering the progression of neurodegenerative ...
Manufactured by:Cytocast based inBudapest, HUNGARY
Cytocast is at the forefront of medical technology with its innovative Cytocast Digital Twin Platform™, a pioneering solution in drug development and personalized medicine. At its core is the CYTOCAST DIGITAL TWIN Cell™, a highly detailed simulated human cell model encompassing 15 tissue types. The platform integrates multi-omics data and bioinformatics within ...
Manufactured by:Population Bio, Inc. a Precision Medicine Company based inMelville, NEW YORK (USA)
Population Bio’s patented CNV Beacon® platform is a rapid genetic discovery method that focuses first on identifying disease-relevant copy number variants (CNVs). Once a gene or genomic region is discovered via a CNV, other types of genetic variants – such as single nucleotide variants (SNVs) – can be efficiently revealed to determine the full spectrum of variants that cause ...
Manufactured by:Diaceutics PLC based inBelfast, UNITED KINGDOM
What is DXRX Physician Mapping? DXRX Physician Mapping examines physician testing behavior (US only) using patient level data to determine testing rates, methodology and the physician to lab relationship. DXRX Physician Mapping highlights suboptimal testing behaviors such as reduced testing rates, slow turnaround time or wrong testing methods and enables the comparison of biomarker testing ...
Manufactured by:Diaceutics PLC based inBelfast, UNITED KINGDOM
What is DXRX Lab Mapping? DXRX Lab Mapping offers global insights into labs currently testing patients diagnosed with a specific disease or biomarker. Labs are ranked by test volume with a range of details provided including test availability, modality, methods, turnaround time and reporting to support pharma in understanding testing ...
Manufactured by:Diaceutics PLC based inBelfast, UNITED KINGDOM
What is DXRX Disease Testing Rate Tracker? DXRX Disease Testing Rate Tracker delivers biomarker testing rate reports showing biomarker testing rates per indication at a national level, delivering an accurate view of testing rates, adoption and trends over ...
Manufactured by:Precision For Medicine, Inc. based inFrederick, MARYLAND (USA)
Clinical and research-grade leukopaks - mobilized or non-mobilized from healthy and diseased subjects, including oncology donors. ...
Manufactured by:Spengler Instruments based inAix-en-Provence, FRANCE
Are you looking for a sphygmomanometer that can be used by all practitioners, both left-handed and right-handed, and that can be passed from hand to hand several times an hour without ever malfunctioning? The LIAN NM is for you! Like all SPENGLER sphygmomanometers, it is both precise and comfortable to use. In addition, it features an easy connection system with a screw thread for changing the ...
Manufactured by:Diaceutics PLC based inBelfast, UNITED KINGDOM
What is DXRX Signal? DXRX Signal delivers an actionable alert of a testing behavior that allows you to engage a physician whilst they are making treatment decisions, therefore maximizing the effectiveness of your brand sales and ...
Manufactured by:Benevolent based inLondon, UNITED KINGDOM
Better target discovery and compound design in Ulcerative Colitis. What is UC?: Ulcerative colitis (UC) is a chronic, lifelong disease that causes inflammation and ulceration of the inner lining of the colon and rectum, accompanied by debilitating symptoms. Our work: There is no cure for UC, current treatments have side effects and don’t work on all patients. Our work focuses on developing ...
Manufactured by:Exscientia based inOxford, UNITED KINGDOM
Target selection is key to creating success in drug discovery. Selecting each target is a significant decision and the future success of any molecule will depend on that initial ...